{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:03:21Z","timestamp":1789056201644,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19) was first detected in December 2019. In March 2020, the World Health Organization declared COVID-19 a pandemic. People with underlying medical conditions may be at greater risk of infection and experience complications from COVID-19. COVID-19 has the potential to affect People living with HIV (PLWH) in various ways, including be increased risk of COVID-19 acquisition and interruptions of HIV treatment and care. The purpose of this review article is to evaluate the impact of COVID-19 among PLWH. The contents focus on 4 topics: (1) the pathophysiology and host immune response of people infected with both SARS-CoV-2 and HIV, (2) present the clinical manifestations and treatment outcomes of persons with co-infection, (3) assess the impact of antiretroviral HIV drugs among PLWH infected with COVID-19 and (4) evaluate the impact of the COVID-19 pandemic on HIV services.<\/jats:p>","DOI":"10.1186\/s12981-021-00335-1","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T11:04:02Z","timestamp":1620212642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["COVID-19 and HIV infection co-pandemics and their impact: a review of the literature"],"prefix":"10.1186","volume":"18","author":[{"given":"Sivaporn","family":"Gatechompol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opass","family":"Putcharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Kuritzkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"335_CR1","unstructured":"WHO. Timeline of WHO\u2019s response to COVID-19; Last updated 30 July 2020. https:\/\/www.who.int\/news-room\/detail\/29-06-2020-covidtimeline. Accessed 1 Nov 2020."},{"key":"335_CR2","unstructured":"The Johns Hopkins Coronavirus Resource Center. COVID-19 data. https:\/\/coronavirus.jhu.edu. Accessed 6 Nov 2020."},{"key":"335_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052\u20139.","journal-title":"JAMA"},{"key":"335_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"335_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/ageing\/afaa093","volume":"49","author":"FE Lithander","year":"2020","unstructured":"Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JCL, et al. COVID-19 in older people: a rapid clinical review. Age Ageing. 2020;49:501\u201315.","journal-title":"Age Ageing"},{"key":"335_CR6","unstructured":"WHO. HIV\/AIDS data and statistic. https:\/\/www.who.int\/hiv\/data\/en\/. Accessed 1 Nov 2020."},{"key":"335_CR7","unstructured":"WHO. Estimated Antiretroviral therapy coverage https:\/\/apps.who.int\/gho\/data\/view.main.23300REGION?lang=en. Accessed 1 Nov 2020."},{"key":"335_CR8","unstructured":"UNAIDS. Global HIV & AIDS statistics\u20142018 fact sheet. Geneva: UNAIDS; 2018. http:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"335_CR9","unstructured":"WHO. Disruption in HIV, Hepatitis and STI services due to COVID-19. https:\/\/www.who.int\/docs\/default-source\/hiv-hq\/presentation-disruption-in-services-international-aids-conference-2020.pdf?sfvrsn=d4bf1f87_7. Accessed 1 Nov 2020."},{"key":"335_CR10","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1056\/NEJMp2008193","volume":"383","author":"WM El-Sadr","year":"2020","unstructured":"El-Sadr WM, Justman J. Africa in the Path of Covid-19. N Engl J Med. 2020;383:e11.","journal-title":"N Engl J Med"},{"key":"335_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100342","volume":"22","author":"PK Drain","year":"2020","unstructured":"Drain PK, Garrett N. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: considerations for COVID-19 in people living with HIV. EClinicalMedicine. 2020;22:","journal-title":"EClinicalMedicine."},{"key":"335_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:","journal-title":"Clin Immunol."},{"key":"335_CR13","first-page":"1","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1\u20139.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"335_CR14","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","volume":"77","author":"BJ Bosch","year":"2003","unstructured":"Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801\u201311.","journal-title":"J Virol"},{"key":"335_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","volume":"525","author":"Y Chen","year":"2020","unstructured":"Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020;525:135\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"335_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562\u20139.","journal-title":"Nat Microbiol."},{"key":"335_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14:185\u201392.","journal-title":"Front Med."},{"key":"335_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0194599820926473","volume":"163","author":"JY Tong","year":"2020","unstructured":"Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 Patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163:3\u201311.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"335_CR19","doi-asserted-by":"publisher","first-page":"eabc5801","DOI":"10.1126\/sciadv.abc5801","volume":"6","author":"DH Brann","year":"2020","unstructured":"Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6:eabc5801.","journal-title":"Sci Adv."},{"key":"335_CR20","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1128\/JVI.01792-08","volume":"83","author":"T Yoshikawa","year":"2009","unstructured":"Yoshikawa T, Hill T, Li K, Peters CJ, Tseng CT. Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J Virol. 2009;83:3039\u201348.","journal-title":"J Virol"},{"key":"335_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","volume":"59","author":"R Channappanavar","year":"2014","unstructured":"Channappanavar R, Zhao J, Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014;59:118\u201328.","journal-title":"Immunol Res"},{"key":"335_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420\u20132.","journal-title":"Lancet Respir Med."},{"key":"335_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782\u201393.","journal-title":"JAMA"},{"key":"335_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.272.5263.872","volume":"272","author":"Y Feng","year":"1996","unstructured":"Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272:872\u20137.","journal-title":"Science."},{"key":"335_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013;254:54\u201364.","journal-title":"Immunol Rev"},{"key":"335_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","volume":"19","author":"G Doitsh","year":"2016","unstructured":"Doitsh G, Greene WC. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe. 2016;19:280\u201391.","journal-title":"Cell Host Microbe"},{"key":"335_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ebiom.2019.07.027","volume":"46","author":"J Alzahrani","year":"2019","unstructured":"Alzahrani J, Hussain T, Simar D, Palchaudhuri R, Abdel-Mohsen M, Crowe SM, et al. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. EBioMedicine. 2019;46:522\u201331.","journal-title":"EBioMedicine."},{"key":"335_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762\u20138.","journal-title":"Clin Infect Dis."},{"key":"335_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061\u20139.","journal-title":"JAMA."},{"key":"335_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/myc.13096","volume":"63","author":"P Koehler","year":"2020","unstructured":"Koehler P, Cornely OA, B\u00f6ttiger BW, Dusse F, Eichenauer DA, Fuchs F, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63:528\u201334.","journal-title":"Mycoses"},{"key":"335_CR31","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, Delli\u00e8re S, Fodil S, Bretagne S, M\u00e9garbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8:e48\u20139.","journal-title":"Lancet Respir Med."},{"key":"335_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266\u201375.","journal-title":"J Infect"},{"key":"335_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1183\/09031936.00186214","volume":"45","author":"S Herold","year":"2015","unstructured":"Herold S, Becker C, Ridge KM, Budinger GRS. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J. 2015;45:1463.","journal-title":"Eur Respir J"},{"key":"335_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","volume":"10","author":"L Rutsaert","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020;10:71.","journal-title":"Ann Intensive Care."},{"key":"335_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11239-020-02224-2","volume":"51","author":"F Du","year":"2021","unstructured":"Du F, Liu B, Zhang S. COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness. J Thromb Thrombolysis. 2021;51:313\u201329.","journal-title":"J Thromb Thrombolysis"},{"key":"335_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1\u201313.","journal-title":"Transl Res."},{"key":"335_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u20137.","journal-title":"Thromb Res"},{"key":"335_CR38","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.030","volume":"3","author":"M Bibas","year":"2011","unstructured":"Bibas M, Biava G, Antinori A. HIV-Associated Venous Thromboembolism. Mediterr J Hematol Infect Dis. 2011;3:","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"335_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajem.2009.09.034","volume":"29","author":"J Malek","year":"2011","unstructured":"Malek J, Rogers R, Kufera J, Hirshon JM. Venous thromboembolic disease in the HIV-infected patient. Am J Emerg Med. 2011;29:278\u201382.","journal-title":"Am J Emerg Med"},{"key":"335_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/apc.2008.0010","volume":"22","author":"NF Crum-Cianflone","year":"2008","unstructured":"Crum-Cianflone NF, Weekes J, Bavaro M. Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS. 2008;22:771\u20138.","journal-title":"AIDS Patient Care STDS."},{"key":"335_CR41","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(20)30164-8","volume":"7","author":"P Vizcarra","year":"2020","unstructured":"Vizcarra P, P\u00e9rez-El\u00edas MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7:e554\u201364.","journal-title":"Lancet HIV."},{"key":"335_CR42","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3550029","volume-title":"A survey for COVID-19 among HIV\/AIDS patients in two districts of Wuhan","author":"W Guo","year":"2020","unstructured":"Guo W, Ming F, Dong Y, Zhang Q, Zhang X, Mo P, et al. A survey for COVID-19 among HIV\/AIDS patients in two districts of Wuhan. SSRN: China; 2020."},{"issue":"3","key":"335_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/infdis\/jiaa380","volume":"223","author":"HE Ho","year":"2020","unstructured":"Ho HE, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, et al. Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV. J Infect Dis. 2020;223(3):403\u20138.","journal-title":"J Infect Dis"},{"issue":"1","key":"335_CR44","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/QAI.0000000000002411","volume":"85","author":"AK Okoh","year":"2020","unstructured":"Okoh AK, Bishburg E, Grinberg S, Nagarakanti S. COVID-19 pneumonia in patients with HIV-a case series. J Acquir Immune Defic Syndr. 2020;85(1):e4\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"335_CR45","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/cid\/ciaa635","volume":"71","author":"N Shalev","year":"2020","unstructured":"Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, et al. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19. Clin Infect Dis. 2020;71(16):2294\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"335_CR46","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/jmv.26077","volume":"92","author":"K Suwanwongse","year":"2020","unstructured":"Suwanwongse K, Shabarek N. Clinical features and outcome of HIV\/SARS-CoV-2 coinfected patients in The Bronx, New York city. J Med Virol. 2020;92(11):2387\u20139.","journal-title":"J Med Virol."},{"key":"335_CR47","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of covid-19 in New York City. N Engl J Med. 2020;382:2372\u20134.","journal-title":"N Engl J Med"},{"key":"335_CR48","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMc2011117","volume":"382","author":"E Akalin","year":"2020","unstructured":"Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382:2475\u20137.","journal-title":"N Engl J Med"},{"issue":"11","key":"335_CR49","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/cid\/ciaa880","volume":"71","author":"K Sigel","year":"2020","unstructured":"Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, et al. Covid-19 and people with HIV infection: outcomes for hospitalized patients in New York City. Clin Infect Dis. 2020;71(11):2933\u20138.","journal-title":"Clin Infect Dis"},{"key":"335_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/QAI.0000000000002423","volume":"85","author":"S Karmen-Tuohy","year":"2020","unstructured":"Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2020;85:6\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"335_CR51","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","volume":"7","author":"JL Blanco","year":"2020","unstructured":"Blanco JL, Ambrosioni J, Garcia F, Mart\u00ednez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7:e314\u20136.","journal-title":"Lancet HIV."},{"key":"335_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25573","volume":"23","author":"KM Byrd","year":"2020","unstructured":"Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, et al. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States. J Int AIDS Soc. 2020;23:","journal-title":"J Int AIDS Soc."},{"issue":"8","key":"335_CR53","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/cid\/ciaa657","volume":"71","author":"K Childs","year":"2020","unstructured":"Childs K, Post FA, Norcross C, Ottaway Z, Hamlyn E, Quinn K, et al. Hospitalized patients with COVID-19 and HIV: a case series. Clin Infect Dis. 2020;71(8):2021\u20132.","journal-title":"Clin Infect Dis"},{"issue":"16","key":"335_CR54","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1093\/cid\/ciaa579","volume":"71","author":"C Gervasoni","year":"2020","unstructured":"Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2276\u20138.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"335_CR55","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1097\/QAD.0000000000002607","volume":"34","author":"EA Meyerowitz","year":"2020","unstructured":"Meyerowitz EA, Kim AY, Ard KL, Basgoz N, Chu JT, Hurtado RM, et al. Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV. Aids. 2020;34(12):1781\u20137.","journal-title":"Aids."},{"key":"335_CR56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/apc.2020.0103","volume":"34","author":"JP Ridgway","year":"2020","unstructured":"Ridgway JP, Farley B, Benoit JL, Frohne C, Hazra A, Pettit N, et al. A case series of five people living with HIV hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDS. 2020;34:331\u20135.","journal-title":"AIDS Patient Care STDS."},{"key":"335_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","volume":"116","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R Jr, Nunneley JW, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015;116:76\u201384.","journal-title":"Antiviral Res"},{"key":"335_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"G Li","year":"2020","unstructured":"Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19:149\u201350.","journal-title":"Nat Rev Drug Discov."},{"key":"335_CR59","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","volume":"212","author":"JF Chan","year":"2015","unstructured":"Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, et al. Treatment with lopinavir\/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis. 2015;212:1904\u201313.","journal-title":"J Infect Dis"},{"key":"335_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"KT Choy","year":"2020","unstructured":"Choy KT, Wong AY, Kaewpreedee P, Sia SF, Chen D, Hui KPY, et al. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020;178:","journal-title":"Antiviral Res"},{"key":"335_CR61","first-page":"e00399","volume":"64","author":"MA Martinez","year":"2019","unstructured":"Martinez MA. Compounds with therapeutic potential against novel respiratory, coronavirus. Antimicrob Agents Chemother. 2019;64:e00399.","journal-title":"Antimicrob Agents Chemother"},{"key":"335_CR62","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/jama.2020.3204","volume":"323","author":"BE Young","year":"2020","unstructured":"Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323:1488\u201394.","journal-title":"JAMA"},{"key":"335_CR63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jmv.25711","volume":"92","author":"W Han","year":"2020","unstructured":"Han W, Quan B, Guo Y, Zhang J, Lu Y, Feng G, et al. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. J Med Virol. 2020;92:461\u20133.","journal-title":"J Med Virol"},{"key":"335_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijid.2020.03.013","volume":"95","author":"F Liu","year":"2020","unstructured":"Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, et al. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis. 2020;95:183\u201391.","journal-title":"Int J Infect Dis."},{"key":"335_CR65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"},{"key":"335_CR66","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020;382:1787\u201399.","journal-title":"N Engl J Med"},{"issue":"10259","key":"335_CR67","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","volume":"396","author":"PW Horby","year":"2020","unstructured":"Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, et al. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396(10259):1345\u201352.","journal-title":"Lancet"},{"key":"335_CR68","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"H Pan","year":"2021","unstructured":"Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, et al. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021;384:497\u2013511.","journal-title":"N Engl J Med."},{"key":"335_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","volume":"97","author":"S De Meyer","year":"2020","unstructured":"De Meyer S, Bojkova D, Cinatl J, Van Damme E, Buyck C, Van Loock M, et al. Lack of antiviral activity of darunavir against SARS-CoV-2. Int J Infect Dis. 2020;97:7\u201310.","journal-title":"Int J Infect Dis."},{"key":"335_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104826","volume":"157","author":"A Riva","year":"2020","unstructured":"Riva A, Conti F, Bernacchia D, Pezzati L, Sollima S, Merli S, et al. Darunavir does not prevent SARS-CoV-2 infection in HIV patients. Pharmacol Res. 2020;157:","journal-title":"Pharmacol Res"},{"key":"335_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA. Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci. 2020;253:","journal-title":"Life Sci"},{"key":"335_CR72","doi-asserted-by":"crossref","unstructured":"Jockusch S, Tao C, Li X, Anderson TK, Chien M, Kumar S, et al. Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase. bioRxiv. 2020; 2020.04.03.022939.","DOI":"10.1101\/2020.04.03.022939"},{"key":"335_CR73","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","volume":"7","author":"BL Jewell","year":"2020","unstructured":"Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV. 2020;7:e629\u201340.","journal-title":"Lancet HIV."},{"key":"335_CR74","first-page":"662","volume":"41","author":"W Guo","year":"2020","unstructured":"Guo W, Weng HL, Bai H, Liu J, Wei XN, Zhou K, et al. Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:662\u20136.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"335_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10461-020-02903-4","volume":"24","author":"S Sun","year":"2020","unstructured":"Sun S, Hou J, Chen Y, Lu Y, Brown L, Operario D. Challenges to HIV care and psychological health during the COVID-19 pandemic among people living with HIV in China. AIDS Behav. 2020;24:1\u20132.","journal-title":"AIDS Behav"},{"key":"335_CR76","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s10461-020-02893-3","volume":"24","author":"RM Pinto","year":"2020","unstructured":"Pinto RM, Park S. COVID-19 pandemic disrupts HIV continuum of care and prevention: implications for research and practice concerning community-based organizations and frontline providers. AIDS Behav. 2020;24:2486\u20139.","journal-title":"AIDS Behav"},{"key":"335_CR77","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s10461-020-02871-9","volume":"24","author":"S Shiau","year":"2020","unstructured":"Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The burden of COVID-19 in people living with HIV: a syndemic perspective. AIDS Behav. 2020;24:2244\u20139.","journal-title":"AIDS Behav"},{"key":"335_CR78","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijid.2020.05.013","volume":"96","author":"JD Kowalska","year":"2020","unstructured":"Kowalska JD, Skrzat-Klapaczy\u0144ska A, Bursa D, Balayan T, Begovac J, Chkhartishvili N, et al. HIV care in times of the COVID-19 crisis - where are we now in Central and Eastern Europe? Int J Infect Dis. 2020;96:311\u20134.","journal-title":"Int J Infect Dis."},{"key":"335_CR79","first-page":"147","volume":"26","author":"KL Rockwell","year":"2020","unstructured":"Rockwell KL, Gilroy A. Incorporating telemedicine as part of COVID-19 outbreak response systems. AJMC. 2020;26:147\u20138.","journal-title":"AJMC."},{"key":"335_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100603","volume":"28","author":"L Cilloni","year":"2020","unstructured":"Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28:","journal-title":"EClinicalMedicine."},{"issue":"2","key":"335_CR81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/sextrans-2020-054805","volume":"97","author":"MA Crane","year":"2020","unstructured":"Crane MA, Popovic A, Stolbach AI, Ghanem KG. Reporting of sexually transmitted infections during the COVID-19 pandemic. Sex Transm Infect. 2020;97(2):101\u20132.","journal-title":"Sex Transm Infect."},{"key":"335_CR82","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S2468-1253(20)30305-8","volume":"5","author":"M Lemoine","year":"2020","unstructured":"Lemoine M, Kim JU, Ndow G, Bah S, Forrest K, Rwegasha J, et al. Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2020;5:966\u20137.","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00335-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-021-00335-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00335-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:15:24Z","timestamp":1675250124000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-021-00335-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["335"],"URL":"https:\/\/doi.org\/10.1186\/s12981-021-00335-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}